Attività assistenziale
Ricoveri ordinari in reparto di degenza, Day Hospital e Day Service.
Laboratorio analisi con esame del liquor EEG Potenziali evocati ENG-EMG RM cerebrale ed angioRM del circolo extra ed intracranico TC cerebrale EcocolorDoppler Tronchi Sovraortici Doppler e ColorDoppler transcranico Doppler transcranico con somministrazione di soluzione fisiologica agitata per la ricerca di shunt cardiaco destro-sinistro in caso di pervietà del forame ovale
infiltrazione del nervo grande occipitale (GON) trattamento di wash out da farmaci trattamento con onabotulinum tossina A trattamento con anticorpi monoclonali per via infusionale terapia di supporto psicoterapico esecuzione di scale validate per la valutazione dell'efficacia della terapia
Attività scientifica
Link pubblicazioni: https://scholar.google.it/citations?hl=it&user=EhhwGWoAAAAJ&view_op=list_works&sortby=pubdate
The objective assessment of sleep in cluster headache: State of the art and future directions M Gorgoni, G Giuliani, M Fratino, V Di Piero Journal of Sleep Research 33 (3), e14103, 2024
Neurophysiological investigations in a case of primary paroxysmal hemicrania-tic syndrome I Maestrini, A Viganò, G Di Stefano, M Toscano, V Di Piero Neurological Sciences, 1-5, 2024
SUNCT syndrome secondary to multiple sclerosis: Not only trigeminal neuralgia G Giuliani, C Zilli, F Caramia, V Di Piero, M Altieri Multiple Sclerosis Journal, 13524585241235535,1, 2024
Exploring the Therapeutic Potential of Quadripulse rTMS over the Visual Cortex: A Proof-of-Concept Study in Healthy Volunteers and Chronic Migraine Patients with Medication … A Viganò, T Sasso D’Elia, SL Sava, A Colosimo, V Di Piero, D Magis, J Schoenen Biomedicines 12 (2), 288, 2024
Trigeminal involvement in conventional MRI is undistinguishable between Trigeminal Neuralgia and SUNCT Syndrome G Giuliani, G De Stefano, C Zilli, M Altieri, F Caramia, G Di Stefano, M Altieri Cephalagia 43 (1 supp), 2023
Neuroimaging markers of Alice in Wonderland syndrome in patients with migraine with aura G Mastria, V Mancini, A Viganò, C Piervincenzi, N Petsas, M Puma, C Giannì, P Pantano, V Di Piero Frontiers in Neurology 14, 1210811, 3, 2023
Case report: Recurrent nocturnal awakenings in cluster headache: a different type of ghost attack G Giuliani, M Gorgoni, M Altieri, V Di Piero Frontiers in Neurology 14, 1230710, 1, 2023
Whole brain surface-based morphometry and tract-based spatial statistics in migraine with aura patients: difference between pure visual and complex auras C Abagnale, A Di Renzo, G Sebastianelli, F Casillo, E Tinelli, G Giuliani, MG Tullo, M Serrao, V Parisi, M. Fiuorelli, F Caramia, J Schoenen, V Di Piero, G Coppola Frontiers in Human Neuroscience 17, 1146302,6, 2023
Profiling the spectrum of headache disorders on 440 breast cancer patients: highlights on clinical and pathological mechanisms MB Ilieva, P Tiberio, R Torrisi, J Lanzone, V Di Piero, A Santoro, A Viganò, R De Sanctis Biomedicines 11 (4), 1059, 3, 2023
Habituation deficit of visual evoked potentials in migraine patients with hypermobile Ehlers-Danlos syndrome I Maestrini, L Rocchi, F Puledda, A Viganò, G Giuliani, TB Jannini, C Celletti, M Altieri, F Camerota, M Toscano, V Di Piero Frontiers in Neurology 14, 1072785, 1, 2023
Functional connectivity alterations in migraineurs with Alice in Wonderland syndrome C Piervincenzi, N Petsas, A Viganò, V Mancini, G Mastria, M Puma, C Giannì, V Di Piero, P Pantano Neurological Sciences 44 (1), 305-317, 8, 2023
Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy: The multicenter prospective cohort GARLIT study Vernieri F, Brunelli N, Marcosano M, Aurilia C, Egeo G, Lovati C, Favoni V, Perrotta A, Maestrini I, Rao R, Onofrio L, Finocchi C, Aguggia M, Bono F, Ranieri A, Albanese M, Di Piero V, Cevoli S, AltamuracC, Barbanti P; GARLIT Study Group European Journal of Neurology 30 (1), 224-234, 33, 2023
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors. Alessiani M, Petolicchio B, De Sanctis R, Squitieri M, Di Giambattista R, Puma M, Franzese C, Toscano M, Derchi CC, Gilliéron E, Viganò A, Di Piero V. European Neurology 85 (6), 453-459, 4, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT study
Responsabile Prof. Vittorio Di Piero |